N-butyl cyanoacrylate glue application in prostate artery embolization for benign prostatic hyperplasia: a systematic review of safety and efficacy.

Date publication

novembre 2025

Journal

CVIR endovascular

Auteurs

Membres identifiés du Cancéropôle Est :
Pr LOFFROY Romaric

Tous les auteurs :
Mohamed NSA, El Khatib E, Justaniah AI, Fouad MEM, Loffroy R

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41186636

Résumé

Benign prostatic hyperplasia (BPH) is the most common urological disorder in older males, often treated with prostate artery embolization (PAE) to alleviate lower urinary tract symptoms. While traditional embolic materials like microspheres are common, issues such as symptom recurrence and non-target embolization remain. This systematic review evaluates the safety and effectiveness of n-butyl cyanoacrylate (NBCA) glue as an alternative embolic agent for PAE.

Mots clés

Benign prostatic hyperplasia, Embolic agents, Interventional radiology, N-butyl cyanoacrylate, Prostate artery embolization

Référence

CVIR Endovasc. 2025 11 4;8(1):98